Insomnia Drugs Market Size, Share & Industry Analysis, By Drug Class (Dual Orexin Receptor Antagonists (DORAs), Z-drugs/Non-Benzodiazepine Hypnotics, Benzodiazepine Hypnotics, Melatonin Pathway Agents, and Others), By Disease Indication (Primary Chronic Insomnia Disorder, Comorbid Psychiatric Insomnia, Comorbid Neurologic/Pain-Related Insomnia, & Others), By Age Group (Adults and Pediatric), By Type (Branded and Generic), By Route of Administration (Oral and Others), By Distribution Channel (Hospital pharmacies, Drug Stores & Retail Pharmacies, & Others), and Regional Forecast, 2026-2034

Last Updated: April 29, 2026 | Format: PDF | Report ID: FBI116040

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 7.86% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Region
By Drug Class	Dual Orexin Receptor Antagonists (DORAs) Z-drugs/Non-Benzodiazepine Hypnotics Benzodiazepine Hypnotics Melatonin Pathway Agents Others
By Disease Indication	Primary Chronic Insomnia Disorder Comorbid Psychiatric Insomnia Comorbid Neurologic/Pain-Related Insomnia Short-Term/Adjustment Insomnia Others
By Age Group	Adults Pediatrics
By Type	Branded Generic
By Route of Administration	Oral Others
By Distribution Channel	Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies
By Region	North America (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Class, Disease Indication, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa